Oncology Institute (DFPH) Cash from Investing Activities (2020 - 2026)

Oncology Institute (DFPH) has 7 years of Cash from Investing Activities data on file, last reported at -$1.0 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 415.84% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.9 million (down 114.7% YoY) and the FY2025 annual result came in at -$3.1 million, down 106.65% from the prior year.
• Cash from Investing Activities improved to -$1.0 million in Q1 2026, from -$1.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $24.9 million in Q2 2023 to a low of -$87.8 million in Q3 2022.
• A 5-year average of -$1.6 million and a median of -$604000.0 in 2025 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 9139.89% — and 2023, when it jumped 1936.43%.
• Tracing DFPH's Cash from Investing Activities over 5 years: stood at -$32.6 million in 2022, then jumped by 135.7% to $11.6 million in 2023, then tumbled by 115.09% to -$1.8 million in 2024, then surged by 39.6% to -$1.1 million in 2025, then grew by 1.7% to -$1.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$1.0 million (Q1 2026), -$1.1 million (Q4 2025), and -$604000.0 (Q3 2025), per Business Quant data.